Potential hemophilia A gene therapy SPK-8011 moves to Phase 3
Roche announces it is initiating a Phase 3 clinical trial to test the experimental hemophilia A gene therapy SPK-8011.
0 Comments
Potential hemophilia A gene therapy SPK-8011 moves to Phase 3
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed